{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T08:45:18Z","timestamp":1790412318292,"version":"4.1.0"},"publisher-location":"New York, NY","reference-count":54,"publisher":"Springer US","isbn-type":[{"value":"9781071644294","type":"print"},{"value":"9781071644300","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-1-0716-4430-0_5","type":"book-chapter","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T15:15:39Z","timestamp":1742310939000},"page":"91-125","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Assessment of Survivorship in Allogeneic Hematopoietic Stem Cell Transplantation"],"prefix":"10.1007","author":[{"given":"Gemma","family":"McErlean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,19]]},"reference":[{"key":"5_CR1","doi-asserted-by":"publisher","DOI":"10.21236\/AD0624870","volume-title":"Training requirements for postattack adaptive behavior. Final report","author":"G Teal","year":"1965","unstructured":"Teal G, Fabrizio R, Barnes S et al (1965) Training requirements for postattack adaptive behavior. Final report. Dunlap and Associates, Inc., Darien, Conn"},{"key":"5_CR2","first-page":"285","volume":"5","author":"A Gilman","year":"1946","unstructured":"Gilman A (1946) Therapeutic applications of chemical warfare agents. Fed Proc 5:285\u2013292","journal-title":"Fed Proc"},{"issue":"5","key":"5_CR3","doi-asserted-by":"publisher","first-page":"908","DOI":"10.3324\/haematol.2013.096461","volume":"99","author":"A Gratwohl","year":"2014","unstructured":"Gratwohl A, Brand R, McGrath E et al (2014) Use of the quality management system \u201cJACIE\u201d and outcome after hematopoietic stem cell transplantation. Haematologica 99(5):908","journal-title":"Haematologica"},{"issue":"7","key":"5_CR4","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41409-021-01227-8","volume":"56","author":"JR Passweg","year":"2021","unstructured":"Passweg JR, Baldomero H, Chabannon C et al (2021) Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years. Bone Marrow Transplant 56(7):651\u20131664","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"5_CR5","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1177\/1049732318797087","volume":"29","author":"D Tindle","year":"2019","unstructured":"Tindle D, Windsor C, Yates P (2019) Centralizing temporality in adolescent and young adult cancer survivorship. Qual Health Res 29(2):173\u2013183","journal-title":"Qual Health Res"},{"key":"5_CR6","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s11764-015-0458-7","volume":"10","author":"D Langbecker","year":"2016","unstructured":"Langbecker D, Ekberg S, Yates P et al (2016) What are the barriers of quality survivorship care for haematology cancer patients? Qualitative insights from cancer nurses. J Cancer Surviv 10:122\u2013130","journal-title":"J Cancer Surviv"},{"issue":"5","key":"5_CR7","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1200\/JCO.2012.46.6854","volume":"31","author":"MS McCabe","year":"2013","unstructured":"McCabe MS, Bhatia S, Oeffinger KC et al (2013) American Society of Clinical Oncology statement: achieving high-quality cancer survivorship care. J Clin Oncol 31(5):631","journal-title":"J Clin Oncol"},{"issue":"3","key":"5_CR8","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3322\/caac.21183","volume":"63","author":"R Cowens-Alvarado","year":"2013","unstructured":"Cowens-Alvarado R, Sharpe K, Pratt-Chapman M et al (2013) Advancing survivorship care through the National Cancer Survivorship Resource Center: developing American Cancer Society guidelines for primary care providers. CA Cancer J Clin 63(3):147\u2013150","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"5_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.bbmt.2016.10.020","volume":"23","author":"M Battiwalla","year":"2017","unstructured":"Battiwalla M, Hashmi S, Majhail N et al (2017) National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: developing recommendations to improve survivorship and long-term outcomes. Biol Blood Marrow Transplant 23(1):6\u20139","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"5_CR10","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s11764-021-01038-2","volume":"16","author":"G McErlean","year":"2022","unstructured":"McErlean G, Brice L, Gilroy N et al (2022) Long-term treatment burden following allogeneic blood and marrow transplantation in NSW, Australia: a cross-sectional survey. J Cancer Surviv 16(2):432\u2013444","journal-title":"J Cancer Surviv"},{"issue":"27","key":"5_CR11","doi-asserted-by":"publisher","first-page":"6596","DOI":"10.1200\/JCO.2005.12.674","volume":"23","author":"KL Syrjala","year":"2005","unstructured":"Syrjala KL, Langer SL, Abrams JR et al (2005) Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls. J Clin Oncol 23(27):6596\u20136606","journal-title":"J Clin Oncol"},{"issue":"17","key":"5_CR12","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1182\/blood-2009-06-229369","volume":"116","author":"CL Sun","year":"2010","unstructured":"Sun CL, Francisco L, Kawashima T et al (2010) Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study. Blood 116(17):3129\u20133139","journal-title":"Blood"},{"issue":"3","key":"5_CR13","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1200\/JCO.2016.68.8457","volume":"35","author":"EJ Chow","year":"2017","unstructured":"Chow EJ, Cushing-Haugen KL, Cheng GS et al (2017) Morbidity and mortality differences between hematopoietic cell transplantation survivors and other cancer survivors. J Clin Oncol 35(3):306\u2013313","journal-title":"J Clin Oncol"},{"issue":"7","key":"5_CR14","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.bbmt.2013.04.002","volume":"19","author":"CL Sun","year":"2013","unstructured":"Sun CL, Kersey JH, Francisco L et al (2013) Burden of morbidity in 10+ year survivors of hematopoietic cell transplantation: report from the bone marrow transplantation survivor study. Biol Blood Marrow Transplant 19(7):1073\u20131080","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"5_CR15","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.1182\/blood-2010-10-263095","volume":"117","author":"BN Savani","year":"2011","unstructured":"Savani BN, Griffith ML, Jagasia S et al (2011) How I treat late effects in adults after allogeneic stem cell transplantation. Blood 117(11):3002\u20133009","journal-title":"Blood"},{"issue":"10","key":"5_CR16","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.1182\/blood-2007-03-082933","volume":"110","author":"S Bhatia","year":"2007","unstructured":"Bhatia S, Francisco L, Carter A et al (2007) Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study. Blood 110(10):3784\u20133792","journal-title":"Blood"},{"key":"5_CR17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1182\/asheducation-2008.1.125","volume":"1","author":"A Tichelli","year":"2008","unstructured":"Tichelli A, Rov\u00f3 A, Gratwohl A (2008) Late pulmonary, cardiovascular, and renal complications after hematopoietic stem cell transplantation and recommended screening practices. Hematology Am Soc Hematol Educ Program 1:125\u2013133","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"2","key":"5_CR18","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.bbmt.2016.08.019","volume":"23","author":"SH Armenian","year":"2017","unstructured":"Armenian SH, Chemaitilly W, Chen M et al (2017) National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: the cardiovascular disease and associated risk factors working group report. Biol Blood Marrow Transplant 23(2):201\u2013210","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"5_CR19","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1007\/s11239-020-02344-9","volume":"51","author":"SJ Rotz","year":"2021","unstructured":"Rotz SJ, Ryan TD, Hayek SS (2021) Cardiovascular disease and its management in children and adults undergoing hematopoietic stem cell transplantation. J Thromb Thrombolysis 51(4):854\u2013869","journal-title":"J Thromb Thrombolysis"},{"issue":"4","key":"5_CR20","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/sj.bmt.1701342","volume":"22","author":"A Mertens","year":"1998","unstructured":"Mertens A, Ramsay N, Kouris S et al (1998) Patterns of gonadal dysfunction following bone marrow transplantation. Bone Marrow Transplant 22(4):345\u2013350","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"5_CR21","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1038\/s41409-021-01414-7","volume":"56","author":"DM Greenfield","year":"2021","unstructured":"Greenfield DM, Salooja N, Peczynski C et al (2021) Metabolic syndrome and cardiovascular disease after haematopoietic cell transplantation (HCT) in adults: an EBMT cross-sectional non-interventional study. Bone Marrow Transplant 56(11):2820\u20132825","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"5_CR22","doi-asserted-by":"publisher","first-page":"4451","DOI":"10.1007\/s00520-019-05020-8","volume":"27","author":"B Gerstl","year":"2019","unstructured":"Gerstl B, Sullivan E, Koch J et al (2019) Reproductive outcomes following a stem cell transplant for a haematological malignancy in female cancer survivors: a systematic review and meta-analysis. Support Care Cancer 27(12):4451\u20134460","journal-title":"Support Care Cancer"},{"issue":"11","key":"5_CR23","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1016\/j.bbmt.2020.07.007","volume":"26","author":"C Bourlon","year":"2020","unstructured":"Bourlon C, Riviello-Goya S, Acosta-Medina AA et al (2020) Outcomes and challenges of reproductive health in hematopoietic stem cell transplantation survivors. Biol Blood Marrow Transplant 26(11):2127\u20132131","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"5_CR24","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.bbmt.2009.08.016","volume":"16","author":"EC Walter","year":"2010","unstructured":"Walter EC, Orozco-Levi M, Ramirez-Sarmiento A et al (2010) Lung function and long-term complications after allogeneic hematopoietic cell transplant. Biol Blood Marrow Transplant 16(1):53\u201361","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"5_CR25","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.bbmt.2019.09.034","volume":"26","author":"DS Wenger","year":"2020","unstructured":"Wenger DS, Triplette M, Crothers K et al (2020) Incidence, risk factors, and outcomes of idiopathic pneumonia syndrome after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 26(2):413\u2013420","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"5_CR26","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1080\/10428194.2016.1211280","volume":"58","author":"M Shadman","year":"2017","unstructured":"Shadman M, Hingorani S, Lanum SA et al (2017) Allogeneic hematopoietic cell transplant for patients with end stage renal disease requiring dialysis \u2013 a single institution experience. Leuk Lymphoma 58(3):740\u2013742","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"5_CR27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.bbmt.2005.08.036","volume":"12","author":"J Delgado","year":"2006","unstructured":"Delgado J, Cooper N, Thomson K et al (2006) The importance of age, fludarabine, and total body irradiation in the incidence and severity of chronic renal failure after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 12(1):75\u201383","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"5_CR28","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1097\/00007890-199911270-00010","volume":"68","author":"A Locasciulli","year":"1999","unstructured":"Locasciulli A, Testa M, Valsecchi MG et al (1999) The role of hepatitis C and B virus infections as risk factors for severe liver complications following allogeneic bmt: a prospective study by the infectious disease working party of the european blood and marrow transplantation group. Transplantation 68(10):1486\u20131491","journal-title":"Transplantation"},{"issue":"7","key":"5_CR29","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.bbmt.2008.04.009","volume":"14","author":"NS Majhail","year":"2008","unstructured":"Majhail NS, DeFor T, Lazarus HM et al (2008) High prevalence of iron overload in adult allogeneic hematopoietic cell transplant survivors. Biol Blood Marrow Transplant 14(7):790\u2013794","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"5_CR30","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1097\/TP.0b013e3181d84c8e","volume":"89","author":"AD Petropoulou","year":"2010","unstructured":"Petropoulou AD, Porcher R, Herr AL et al (2010) Prospective assessment of bone turnover and clinical bone diseases after allogeneic hematopoietic stem-cell transplantation. Transplantation 89(11):1354\u20131361","journal-title":"Transplantation"},{"issue":"18","key":"5_CR31","doi-asserted-by":"publisher","first-page":"4127","DOI":"10.1002\/cncr.24474","volume":"115","author":"S Campbell","year":"2009","unstructured":"Campbell S, Sun CL, Kurian S et al (2009) Predictors of avascular necrosis of bone in long-term survivors of hematopoietic cell transplantation. Cancer 115(18):4127\u20134135","journal-title":"Cancer"},{"issue":"10","key":"5_CR32","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1016\/j.bbmt.2020.07.001","volume":"26","author":"M Bar","year":"2020","unstructured":"Bar M, Ott SM, Lewiecki EM et al (2020) Bone health management after hematopoietic cell transplantation: an expert panel opinion from the American Society for Transplantation and Cellular Therapy. Biol Blood Marrow Transplant 26(10):1784\u20131802","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"5_CR33","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.bbmt.2008.05.016","volume":"14","author":"S Pavletic","year":"2008","unstructured":"Pavletic S, Vogelsand GB (2008) Treatment of high-risk chronic GVHD. Biol Blood Marrow Transplant 14(12):1436\u20131437","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"5_CR34","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.beha.2008.02.010","volume":"21","author":"JW Lee","year":"2008","unstructured":"Lee JW, Deeg HJ (2008) Prevention of chronic GVHD. Best Pract Res Clin Haematol 21(2):259\u2013270","journal-title":"Best Pract Res Clin Haematol"},{"issue":"6","key":"5_CR35","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.3324\/haematol.2009.018853","volume":"95","author":"E Corre","year":"2010","unstructured":"Corre E, Carmagnat M, Busson M et al (2010) Long-term immune deficiency after allogeneic stem cell transplantation: B-cell deficiency is associated with late infections. Haematologica 95(6):1025","journal-title":"Haematologica"},{"issue":"8","key":"5_CR36","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/bmt.2009.254","volume":"44","author":"M Tomblyn","year":"2009","unstructured":"Tomblyn M, Chiller T, Einsele H et al (2009) Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective. Bone Marrow Transplant 44(8):453\u2013455","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"5_CR37","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.bbmt.2018.09.031","volume":"25","author":"M Norkin","year":"2019","unstructured":"Norkin M, Shaw BE, Brazauskas R et al (2019) Characteristics of late fatal infections after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 25(2):362\u2013368","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"5_CR38","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1200\/JCO.2005.02.7052","volume":"24","author":"W Leisenring","year":"2006","unstructured":"Leisenring W, Friedman DL, Flowers ME et al (2006) Nonmelanoma skin and mucosal cancers after hematopoietic cell transplantation. J Clin Oncol 24(7):1119\u20131126","journal-title":"J Clin Oncol"},{"issue":"2","key":"5_CR39","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1182\/blood-2007-07-099283","volume":"111","author":"DL Friedman","year":"2008","unstructured":"Friedman DL, Rovo A, Leisenring W et al (2008) Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party. Blood 111(2):939\u2013944","journal-title":"Blood"},{"issue":"1","key":"5_CR40","doi-asserted-by":"publisher","first-page":"S139","DOI":"10.1016\/j.bbmt.2011.10.005","volume":"18","author":"G Soci\u00e9","year":"2012","unstructured":"Soci\u00e9 G, Baker KS, Bhatia S (2012) Subsequent malignant neoplasms after hematopoietic cell transplantation. Biol Blood Marrow Transplant 18(1):S139\u2013S150","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"5_CR41","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.4103\/ijo.IJO_2016_20","volume":"69","author":"S Nair","year":"2021","unstructured":"Nair S, Vanathi M, Mukhija R et al (2021) Update on ocular graft-versus-host disease. Indian J Ophthalmol 69(5):1038\u20131050","journal-title":"Indian J Ophthalmol"},{"issue":"5","key":"5_CR42","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/s41409-018-0339-6","volume":"54","author":"Y Inamoto","year":"2019","unstructured":"Inamoto Y, Petricek I, Burns L et al (2019) Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT. Bone Marrow Transplant 54(5):648\u2013661","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"5_CR43","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/s41409-017-0055-7","volume":"53","author":"D Buchbinder","year":"2018","unstructured":"Buchbinder D, Kelly DL, Duarte RF et al (2018) Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT. Bone Marrow Transplant 53(5):535\u2013555","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"5_CR44","doi-asserted-by":"publisher","first-page":"184","DOI":"10.7326\/0003-4819-126-3-199702010-00002","volume":"126","author":"T Duell","year":"1997","unstructured":"Duell T, van Lint MT, Ljungman P et al (1997) Health and functional status of long-term survivors of bone marrow transplantation. Ann Intern Med 126(3):184\u2013192","journal-title":"Ann Intern Med"},{"issue":"1","key":"5_CR45","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1200\/JCO.2011.38.4594","volume":"30","author":"N Khera","year":"2012","unstructured":"Khera N, Storer B, Flowers ME et al (2012) Nonmalignant late effects and compromised functional status in survivors of hematopoietic cell transplantation. J Clin Oncol 30(1):71\u201377","journal-title":"J Clin Oncol"},{"issue":"7","key":"5_CR46","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1038\/s41409-018-0098-4","volume":"53","author":"G Dyer","year":"2018","unstructured":"Dyer G, Brice L, Gilroy N et al (2018) Changes to work status and household income of long-term allogeneic blood and marrow transplant survivors in New South Wales, Australia. Bone Marrow Transplant 53(7):926\u2013931","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"5_CR47","doi-asserted-by":"publisher","first-page":"679.e1","DOI":"10.1016\/j.jtct.2021.04.013","volume":"27","author":"NS Bhatt","year":"2021","unstructured":"Bhatt NS, Brazauskas R, Salit RB et al (2021) Return to work among young adult survivors of allogeneic hematopoietic cell transplantation in the United States. Transplant Cell Ther 27(8):679.e1\u2013679.e8","journal-title":"Transplant Cell Ther"},{"issue":"12","key":"5_CR48","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/bmt.2008.253","volume":"42","author":"S Bieri","year":"2008","unstructured":"Bieri S, Roosnek E, Helg C et al (2008) Quality of life and social integration after allogeneic hematopoietic SCT. Bone Marrow Transplant 42(12):819\u2013827","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"5_CR49","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00520-016-3418-5","volume":"25","author":"L Brice","year":"2017","unstructured":"Brice L, Gilroy N, Dyer G et al (2017) Haematopoietic stem cell transplantation survivorship and quality of life: is it a small world after all? Support Care Cancer 25(2):421\u2013427","journal-title":"Support Care Cancer"},{"key":"5_CR50","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jtct.2023.12.001","volume":"30","author":"SJ Rotz","year":"2024","unstructured":"Rotz SJ, Bhatt NS, Hamilton BK et al (2024) International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: a 2023 update. Transplant Cell Ther 30:349","journal-title":"Transplant Cell Ther"},{"issue":"1","key":"5_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5144\/1658-3876.2012.1","volume":"5","author":"NS Majhail","year":"2012","unstructured":"Majhail NS, Rizzo JD, Lee S et al (2012) Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Hematol Oncol Stem Cell Ther 5(1):1\u201330","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"2","key":"5_CR52","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.bbmt.2005.09.012","volume":"12","author":"JD Rizzo","year":"2006","unstructured":"Rizzo JD, Wingard JR, Tichelli A et al (2006) Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant 12(2):138\u2013151","journal-title":"Biol Blood Marrow Transplant"},{"key":"5_CR53","unstructured":"Childrens Oncology Group. Children\u2019s Oncology Group long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers version 5.0. 2018. Available from: http:\/\/survivorshipguidelines.org\/pdf\/2018\/COG_LTFU_Guidelines_v5.pdf"},{"issue":"6","key":"5_CR54","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1001\/jamaoncol.2018.6634","volume":"5","author":"EAM Feijen","year":"2019","unstructured":"Feijen EAM, Leisenring WM, Stratton KL et al (2019) Derivation of anthracycline and anthraquinone equivalence ratios to doxorubicin for late-onset cardiotoxicity. JAMA Oncol 5(6):864\u2013871","journal-title":"JAMA Oncol"}],"container-title":["Methods in Molecular Biology","Graft-Versus-Host Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-4430-0_5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T15:15:43Z","timestamp":1742310943000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-4430-0_5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9781071644294","9781071644300"],"references-count":54,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-4430-0_5","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"19 March 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}